The EU-X-CT Recommendations on
Cross-Border Access to Clinical Trials

Public Consultation Ends in:

What are the EU-X-CT Recommendations?

To address the current challenges faced by cross-border participants in clinical trials, the EU-X-CT initiative has developed general recommendations on key aspects of clinical trial management and conduct. The recommendations aim to improve safe and equitable access to cross-border clinical trials within Europe.

This document was developed in consultation with over 100 members from 32 countries. Currently in the draft stage, the recommendations will be finalized following a public consultation to ensure all stakeholder perspectives are considered.

Borders Should No Longer Be Barriers In Clinical Trials.

Public Consultation — Your Feedback Matters

The draft recommendations are now open for public consultation. We need your feedback to ensure these recommendations work for all stakeholders involved in cross-border clinical trials.

Duration: 5 Weeks, from 03 February 2025 to 10 March 2025, 12.00 PM CET

How to Provide Feedback

  • Download the Draft Recommendations and the Comments Document below.
  • Fill out the Comments Document following the guidelines mentioned in the document.
  • Email the Comments Document to eu-x-ct@efgcp.eu before the close of the public consultation period.

We look forward to receiving your valuable feedback.